Osteomyelitis and non-coding RNAS: A new dimension in disease understanding
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Md Sadique Hussain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan 302017, India. Hauptthemen laut MEDLINE: Osteomyelitis, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 208 Literaturangaben.
Abstract (Originalsprache)
Osteomyelitis, a debilitating bone infection, presents considerable clinical challenges due to its intricate etiology and limited treatment options. Despite strides in surgical and chemotherapeutic interventions, the treatment landscape for osteomyelitis remains unsatisfactory. Recent attention has focused on the role of non-coding RNAs (ncRNAs) in the pathogenesis and progression of osteomyelitis. This review consolidates current knowledge on the involvement of distinct classes of ncRNAs, including microRNAs, long ncRNAs, and circular RNAs, in the context of osteomyelitis. Emerging evidence from various studies underscores the potential of ncRNAs in orchestrating gene expression and influencing the differentiation of osteoblasts and osteoclasts, pivotal processes in bone formation. The review initiates by elucidating the regulatory functions of ncRNAs in fundamental cellular processes such as inflammation, immune response, and bone remodeling, pivotal in osteomyelitis pathology. It delves into the intricate network of interactions between ncRNAs and their target genes, illuminating how dysregulation contributes to the establishment and persistence of osteomyelitic infections. Understanding their regulatory roles may pave the way for targeted diagnostic tools and innovative therapeutic interventions, promising a paradigm shift in the clinical approach to this challenging condition. Additionally, we delve into the promising therapeutic applications of these molecules, envisioning novel diagnostic and treatment approaches to enhance the management of this challenging bone infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan 302017, India.
- Department of Quality Assurance, Smt. N. M. Padalia Pharmacy College, Ahmedabad, 382210 Gujarat, India.
- Department of Pharmacology, School of Medical & Allied Sciences, K.R. Mangalam University, Gurugram 122103, India.
- Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China. Electronic address: mtufail0276@gmail.com.
- School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand 248001, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Zitieren
APA
Hussain, M. S., Shaikh, N. K., Agrawal, M., Tufail, M., Bisht, A. S., Khurana, N., & Kumar, R. (2024). Osteomyelitis and non-coding RNAS: A new dimension in disease understanding. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155186
Vancouver
Hussain MS, Shaikh NK, Agrawal M, Tufail M, Bisht AS, Khurana N, et al. Osteomyelitis and non-coding RNAS: A new dimension in disease understanding. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155186
BibTeX
@article{Hussain2024,
author = {Hussain, Md Sadique and Shaikh, Nusrat K and Agrawal, Mohit and Tufail, Muhammad and Bisht, Ajay Singh and Khurana, Navneet and Kumar, Rajesh},
title = {Osteomyelitis and non-coding RNAS: A new dimension in disease understanding},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155186}
}
EUVIMED